Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides

Clinical trial NCT04676087 · TERMINATED

Trial details

NCT number: NCT04676087
Sponsor: Emory University
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mycosis Fungoides Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Sezary Syndrome

Start date: 2021-04-21
Primary completion: 2023-10-11
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.